Help us HAMAPASAP!
In order to Help As Many As Possible As Soon As Possible (HAMAPASAP) we are expanding our USP/DSP Team.
Your role at Micreos
For our USP/DSP team in Bilthoven (RIVM grounds) we are looking for an USP/DSP Operator. You are enthusiastic and comfortable in a dynamic environment and you enjoy working in a high demanding and ambitious work environment.
Main objectives of the role
-
Carry out the upstream and downstream process of Staphefekt™ production
-
Typical techniques that are used are fermentation and concentration/diafiltration for cell harvest
-
Reporting and documentation according to standard operating procedures
-
Assist in generation and execution of corrective and preventive actions and proactively suggest quality improvements
-
Write and or update standard operating procedures
-
Prepare required starting materials and maintain inventory of these materials
-
Perform system qualification/calibration activities
-
Assist co-workers in the manufacturing and development team when applicable
Requirements
-
Education (MLO 4 or higher) in Microbiology, Biotechnology, Life sciences, Molecular Biology or equivalent
-
At least 2 years of experience with fermentation techniques
-
Experience with purification techniques is a plus
-
Experience with working in pharmaceutical/medical device industry, where GMP or ISO standards are used is a plus
-
Fluent in Dutch and proficient in English
-
You have an analytical mindset
-
You are a result-focused and driven person with a problem solving attitude
-
You are enthusiastic, proactive and an accurate team player
Our offer
Micreos offers a varied full time role within a young and enthusiastic team and you will be given the opportunity to make the fullest use of your talents. We offer you an ambitious and pleasant international working environment.
Is this the role you are looking for?
Our Micreos HR team is looking forward to receiving your CV and cover letter via recruitment@micreos.com.
Please only apply if your eligible to work in the Netherlands.
Company profile:
Bacteria are all around us. Most of them are good and protect us, but some can cause irritation or infection. Antibiotics do not distinguish between good and bad bacteria and their use can lead to side effects and resistance. As they have been broadly used - often inappropriately - the emergence of antibiotic-resistant 'superbugs' is now a global concern. On the other hand, it has become evident that our microbiome, comprising billions of beneficial bacteria, is necessary for our health and should be left intact.
Micreos develops the world's first targeted antibacterial products, set to replace antibiotics. The company is viewed as global leader spearheading this exciting new field. With Micreos endolysin technology, for the first time we can kill only the unwanted bacteria - including antibiotic resistant strains - while leaving the beneficial bacteria intact. In addition, research shows that the use of endolysins does not induce resistance. This unlocks a completely new approach in dealing with the bacteria around us - also enabling daily use, as long as needed while preserving the important biodiversity on our skin and in our gut. Based on its technology platform, Micreos has launched several products for inflammatory skin conditions such as acne, eczema and rosacea (brandname: Gladskin) and several food safety products marketed under the Phageguard brand. Micreos is also developing pharmaceutical products. See also www.micreos.com and www.gladskin.com
Acquisitions following this vacancy are not appreciated.